C section News and Research

RSS

AcelRx Pharmaceuticals announces financial results for fourth quarter and full year 2013

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported financial results for the three and twelve months ended December 31, 2013.

4 Mar 2014

Research: Microbes living in gut help drive development of intestinal tumors

It is not only genetics that predispose to bowel cancer; microbes living in the gut help drive the development of intestinal tumors, according to new research in mice published in the March issue of The Journal of Experimental Medicine.

4 Mar 2014

Cell Therapeutics initiates Phase 3 clinical trial to evaluate pacritinib in patients with myelofibrosis

Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced the initiation of a Phase 3 clinical trial, known as PERSIST-2, which will evaluate pacritinib, a novel, investigational JAK2/FLT3 inhibitor, in patients with myelofibrosis whose platelet counts are less than or equal to 100,000 per microliter (uL).

3 Mar 2014

Teen diagnosed with liver cancer explores genetic link to rare cancers

A father-daughter scientific collaboration that began after the daughter was diagnosed with a rare liver cancer has led to an important finding and could have broader implications for many other rare cancers. Their story is being published this week in a top tier journal, Science.

3 Mar 2014

NCI scientist recognized for AACR-American Cancer Society Award for Excellence in Cancer Epidemiology and Prevention

The American Association for Cancer Research (AACR) and the American Cancer Society will recognize Curtis C. Harris, M.D., with the 23rd Annual AACR-American Cancer Society Award for Excellence in Cancer Epidemiology and Prevention at the AACR Annual Meeting 2014, to be held in San Diego, Calif., April 5-9.

3 Mar 2014

Endo Health Solutions Reports net loss of $776M in fourth quarter 2013

Endo Health Solutions today reported fourth quarter 2013 revenues of $585 million, compared to $750 million for the same quarter of 2012.

28 Feb 2014

Loyola University Medical Center offers new high-tech catheter device for treating atrial fibrillation

Loyola University Medical Center is the first hospital in Illinois to offer a new high-tech catheter device that can improve outcomes of patients treated for atrial fibrillation, the most common irregular heartbeat.

28 Feb 2014

New procedure offers benefits for patients with severe asthma

Like millions of people, Jeannine Childs suffers from asthma. But unlike most, her asthma was debilitating. For years she struggled with wheezing, shortness of breath and fits of coughing so severe that they often landed her in the hospital. Nothing was really working – not lifestyle changes, not medications.

28 Feb 2014

Babies delivered by C-section may be more likely to become obese

Babies that are delivered by caeserean section are more likely to become overweight or obese as adults, according to researchers from Imperial College, London.

27 Feb 2014

Cedars-Sinai researchers develop unique imaging device to "light up" malignant brain tumors

Researchers at the Cedars-Sinai Maxine Dunitz Neurosurgical Institute and Department of Neurosurgery have developed a unique, compact, relatively inexpensive imaging device to "light up" malignant brain tumors and other cancers.

27 Feb 2014

Somali Americans develop twice antibody response to rubella from current vaccine

Somali Americans develop twice the antibody response to rubella from the current vaccine compared to Caucasians in a new Mayo Clinic study on individualized aspects of immune response.

27 Feb 2014

States: Calif. malpractice bill; Conn. braces for mental health cuts; Fla. advance practice nurses bill

A selection of health policy stories from California, Connecticut, Florida and Arizona.

26 Feb 2014

AMIC provides report on FDA pre-market notification related to brachytherapy cancer product

Advanced Medical Isotope Corporation ("AMIC"), a company engaged in the development, production and distribution of medical isotopes focused on yttrium-90 brachytherapy devices, today announced that it has received a response from the FDA to its pre-market notification to the FDA pursuant to Section 510(k) of the U.S. Food, Drug and Cosmetic Act for its Yttrium-90 (Y-90) RadioGel(tm) patented brachytherapy cancer product.

25 Feb 2014

Greatbatch announces results for fourth quarter and full-year ended 2014

Greatbatch, Inc., today announced results for its fourth quarter and full-year ended January 3, 2014 highlighted by 5% constant currency organic revenue growth for the full year 2013; 12% year over year improvement in adjusted operating income; and 19% improvement in adjusted diluted EPS over 2012.

25 Feb 2014

State highlights: 'Health care homes' show promise in Minn.; Texas women's health providers; Fla.'s hidden costs

A selection of health policy stories from Minnesota, Texas, Louisiana, Florida, New York and Massachusetts.

24 Feb 2014

Doctors' groups urge members to reduce number of C-sections

The move is designed to reduce the risk of unnecessary surgery, but some physicians may resist the effort. Women with low-risk pregnancies should be allowed to spend more time in labor, to reduce the risk of having an unnecessary C-section, the nation's obstetricians say.

24 Feb 2014

First Edition: February 21, 2014

Today's headlines include reports checking the status of different state health exchanges as well as efforts to expand Medicaid.

21 Feb 2014

XenoPort reports net loss of $19.1 million for fourth quarter 2013

XenoPort, Inc. announced today its financial results for the fourth quarter and year ended December 31, 2013. Revenues for the fourth quarter were $2.9 million, compared to $0.5 million for the same period in 2012. Net loss for the fourth quarter was $19.1 million compared to net income of $3.0 million that resulted from a non-cash gain from XenoPort's litigation settlement with Glaxo Group Limited in the fourth quarter of 2012. At December 31, 2013, XenoPort had cash and cash equivalents and short-term investments of $58.7 million.

20 Feb 2014

Highlights: Ohio gov.'s evolving stances; Conn. social services woes; abortion-ban push continues

A selection of health policy stories from Ohio, Connecticut, South Carolina, Mississippi, Florida, California, New York, Oklahoma, Washington, Massachusetts, North Carolina, Texas, Virginia and Georgia.

19 Feb 2014

Specific genes and factors can lead to delays in language development in kids

Boys are at greater risk for delayed language development than girls, according to a new study using data from the Norwegian Mother and Child Cohort Study. The researchers also found that reading and writing difficulties in the family gave an increased risk.

19 Feb 2014

C section News and Research

AcelRx Pharmaceuticals announces financial results for fourth quarter and full year 2013

Research: Microbes living in gut help drive development of intestinal tumors

Cell Therapeutics initiates Phase 3 clinical trial to evaluate pacritinib in patients with myelofibrosis

Teen diagnosed with liver cancer explores genetic link to rare cancers

NCI scientist recognized for AACR-American Cancer Society Award for Excellence in Cancer Epidemiology and Prevention

Endo Health Solutions Reports net loss of $776M in fourth quarter 2013

Loyola University Medical Center offers new high-tech catheter device for treating atrial fibrillation

New procedure offers benefits for patients with severe asthma

Babies delivered by C-section may be more likely to become obese

Cedars-Sinai researchers develop unique imaging device to "light up" malignant brain tumors

Somali Americans develop twice antibody response to rubella from current vaccine

States: Calif. malpractice bill; Conn. braces for mental health cuts; Fla. advance practice nurses bill

AMIC provides report on FDA pre-market notification related to brachytherapy cancer product

Greatbatch announces results for fourth quarter and full-year ended 2014

State highlights: 'Health care homes' show promise in Minn.; Texas women's health providers; Fla.'s hidden costs

Doctors' groups urge members to reduce number of C-sections

First Edition: February 21, 2014

XenoPort reports net loss of $19.1 million for fourth quarter 2013

Highlights: Ohio gov.'s evolving stances; Conn. social services woes; abortion-ban push continues

Specific genes and factors can lead to delays in language development in kids

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News